Literature DB >> 25210684

Minimally invasive techniques for an intersphincteric resection and lateral pelvic lymph node dissection in rectal cancer.

Jung Wook Huh1.   

Abstract

Entities:  

Year:  2014        PMID: 25210684      PMCID: PMC4155134          DOI: 10.3393/ac.2014.30.4.163

Source DB:  PubMed          Journal:  Ann Coloproctol        ISSN: 2287-9714


× No keyword cloud information.
A proper total mesorectal excision (TME) technique is paramount to the successful treatment of locally advanced rectal cancer irrespective of operative method, including open and minimally-invasive approaches. The use of minimally-invasive surgery is of growing interest for the treatment of rectal cancer. The results of a recent, multicenter, randomized COREAN trial and of the COlorectal cancer Laparoscopic or Open Resection (COLOR II) trial suggested that high-quality laparoscopic TME in rectal cancer could be safely achieved through proper patient selection when performed by a skilled surgeon [1, 2]. Moreover, robot-assisted rectal surgery has recently been introduced as a minimally-invasive alternative. Several retrospective analyses have suggested that robotic surgery has several technical advantages and may lead to favorable patient outcomes, although it still has a few drawbacks, including a long operation time and high cost [3, 4, 5]. The potential benefits of laparoscopic colorectal surgery compared with open surgery include faster recovery, lower morbidity, less pain, and a shorter hospital stay, and these can be achieved without compromising oncologic outcomes [6]. Although a laparoscopic colorectal resection is now an established treatment for colorectal cancer, a belief exists that laparoscopic colorectal surgery is not suitable for tumors that have invaded adjacent organs or structures due to its having high morbidities, conversion rates, and questionable oncologic outcomes. Especially, an open resection for an intersphincteric resection (ISR) and a lateral pelvic lymph node dissection (LPND) in rectal cancer remains a very troublesome and demanding procedure; therefore, it would become even more difficult when performed laparoscopically. More recently, with advances in modern laparoscopic technology, a minimally-invasive laparoscopic resection for these circumstances has been reported. I previously suggested that a laparoscopic resection for colorectal cancer could be achieved with low rates of conversion and morbidity even in patients with a preoperatively-suspected T4 tumor, which is associated with the acceptable perioperative outcomes and the disease-free survival rates when compared with an open resection [7]. Moreover, I believe that patients with demanding conditions, such as duodenal or pancreatic invasion in right-sided colon cancer, complex pelvic irregularities or bladder invasion in rectal cancer, or severe intra-abdominal adhesion due to multiple previous surgeries, should immediately be considered for open surgery or looked at laparoscopically with a high suspicion that the surgery would be converted to an open procedure [7]. Although proper patient selection is one of the most important factors for minimally-invasive surgery, many skilled surgeons who have overcome the learning curve for minimally-invasive surgery tend to expand the operative indications for a minimally-invasive procedure. Therefore, I would like to review the more complex minimally-invasive procedures for patients with advanced rectal cancer. A number of recent retrospective studies have indicated that more complex minimally-invasive procedures, such as ISR and LPND are frequently performed by skilled surgeons [5, 8, 9, 10, 11]. Park et al. [10] suggested that a laparoscopic ISR group had a shorter hospital stay and shorter time to bowel movement compared with a matched open ISR group; the local recurrence rate and the 3-year disease-free survival were similar between the two groups during a median follow-up period of 34 months. Lim et al. [11] revealed that 101 patients who underwent a laparoscopic ISR after preoperative chemoradiotherapy for rectal cancer demonstrated a relatively preserved Wexner continence score of 7.5 after ileostomy closure, that observation being based on a questionnaire on postoperative anal function. Moreover, some skilled surgeons believe that a robotic ISR is also feasible and safe for patients with low-lying rectal cancer. In a retrospective comparative study of 84 coloanal anastomoses, Baek et al. [5] showed a lower incidence of conversion to open surgery (2.1% vs. 16.2%) and a shorter hospital stay (9 days vs. 11 days) for the robotic than for the laparoscopic coloanal anastomosis group. In an era of frequent advances in preoperative chemoradiotherapy for locally-advanced rectal cancer, the role of an extended LPND following a TME for this disease is still controversial. A recent meta-analysis comparing an extended and a nonextended LPND in patients with rectal cancer revealed no overall difference in cancer-specific outcomes [8]. For patients with persistent enlargement of lymph nodes even after preoperative chemoradiotherapy, many surgeons selectively performed a LPND. Park et al. [9] also indicated that the surgical strategy regarding a LPND, in addition to a TME, has changed due to the introduction of preoperative chemoradiotherapy. The authors suggested several potential benefits of a laparoscopic LPND over the open technique. First, laparoscopic surgery provided magnified and clear vision of the smallest structure in the narrow pelvis, and protecting the autonomic nerve plexus was easier. Second, the use of an advanced energy device during surgery resulted in favorable early postoperative outcomes. Finally, laparoscopic surgeries involve only a small abdominal incision and potentially reduce the risk of peritoneal adhesion. Robotic surgery can potentially provide articulated movement, elimination of tremors, and a magnified three-dimensional view in a limited space. In a series of 8 consecutive robotic LPNDs, Park et al. [12] reported that the mean operating time for an extended LPND was 38 minutes (range, 20 to 51 minutes) and that no LPND-related morbidities had occurred. In conclusion, the potential benefits of minimally-invasive approaches in patients who undergo an ISR, as well as an extended LPND, can be achieved in a setting of high patient selectivity with surgeons experienced in minimally-invasive surgical techniques. Well-organized, prospective, randomized studies are needed to establish the advantage of minimally-invasive approaches over open surgery in the treatment of patients with locally-advanced rectal cancer.
  12 in total

1.  Laparoscopic versus open intersphincteric resection and coloanal anastomosis for low rectal cancer: intermediate-term oncologic outcomes.

Authors:  Jun Seok Park; Gyu-Seog Choi; Soo Han Jun; Suguru Hasegawa; Yoshiharu Sakai
Journal:  Ann Surg       Date:  2011-12       Impact factor: 12.969

2.  Laparoscopic intersphincteric resection for low rectal cancer.

Authors:  Sang Woo Lim; Jung Wook Huh; Young Jin Kim; Hyeong Rok Kim
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

Review 3.  Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis.

Authors:  Panagiotis Georgiou; Emile Tan; Nikolaos Gouvas; Anthony Antoniou; Gina Brown; R John Nicholls; Paris Tekkis
Journal:  Lancet Oncol       Date:  2009-09-18       Impact factor: 41.316

4.  The feasibility of laparoscopic resection compared to open surgery in clinically suspected T4 colorectal cancer.

Authors:  Jung Wook Huh; Hyeong Rok Kim
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2012-03-06       Impact factor: 1.878

5.  Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial.

Authors:  Sung-Bum Kang; Ji Won Park; Seung-Yong Jeong; Byung Ho Nam; Hyo Seong Choi; Duck-Woo Kim; Seok-Byung Lim; Taek-Gu Lee; Dae Yong Kim; Jae-Sung Kim; Hee Jin Chang; Hye-Seung Lee; Sun Young Kim; Kyung Hae Jung; Yong Sang Hong; Jee Hyun Kim; Dae Kyung Sohn; Dae-Hyun Kim; Jae Hwan Oh
Journal:  Lancet Oncol       Date:  2010-06-16       Impact factor: 41.316

6.  Open versus robot-assisted sphincter-saving operations in rectal cancer patients: techniques and comparison of outcomes between groups of 100 matched patients.

Authors:  Jin C Kim; Sung S Yang; Tae Y Jang; Jae Y Kwak; Myung J Yun; Seok B Lim
Journal:  Int J Med Robot       Date:  2012-08-15       Impact factor: 2.547

7.  Laparoscopic extended lateral pelvic node dissection following total mesorectal excision for advanced rectal cancer: initial clinical experience.

Authors:  Jun Seok Park; Gyu-Seog Choi; Kyoung Hoon Lim; You Seok Jang; Hye Jin Kim; Soo Yeon Park; Soo Han Jun
Journal:  Surg Endosc       Date:  2011-05-10       Impact factor: 4.584

8.  Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial.

Authors:  Pierre J Guillou; Philip Quirke; Helen Thorpe; Joanne Walker; David G Jayne; Adrian M H Smith; Richard M Heath; Julia M Brown
Journal:  Lancet       Date:  2005 May 14-20       Impact factor: 79.321

9.  Robotic versus laparoscopic coloanal anastomosis with or without intersphincteric resection for rectal cancer.

Authors:  Se Jin Baek; Sami Al-Asari; Duck Hyoun Jeong; Hyuk Hur; Byung Soh Min; Seung Hyuk Baik; Nam Kyu Kim
Journal:  Surg Endosc       Date:  2013-05-25       Impact factor: 4.584

10.  Initial clinical experience with robotic lateral pelvic lymph node dissection for advanced rectal cancer.

Authors:  Ju-A Park; Gyu-Seog Choi; Jun Seok Park; Soo Yeun Park
Journal:  J Korean Soc Coloproctol       Date:  2012-10-31
View more
  3 in total

Review 1.  Laparoscopic intersphincteric resection versus an open approach for low rectal cancer: a meta-analysis.

Authors:  Hanyu Chen; Bin Ma; Peng Gao; Hongchi Wang; Yongxi Song; Linhao Tong; Peiwen Li; Zhenning Wang
Journal:  World J Surg Oncol       Date:  2017-12-28       Impact factor: 2.754

2.  Laparoscopic and open surgery in rectal cancer patients in Germany: short and long-term results of a large 10-year population-based cohort.

Authors:  Valentin Schnitzbauer; Michael Gerken; Stefan Benz; Vinzenz Völkel; Teresa Draeger; Alois Fürst; Monika Klinkhammer-Schalke
Journal:  Surg Endosc       Date:  2019-05-30       Impact factor: 4.584

Review 3.  Robotic Intersphincteric Resection for Low Rectal Cancer: Technical Controversies and a Systematic Review on the Perioperative, Oncological, and Functional Outcomes.

Authors:  Guglielmo Niccolò Piozzi; Seon Hahn Kim
Journal:  Ann Coloproctol       Date:  2021-11-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.